{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:11:03Z","timestamp":1788865863874,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijantimicag.2026.107904","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:44:36Z","timestamp":1783147476000},"page":"107904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing and regimen of antiretroviral therapy and all-cause mortality in people with HIV: A time-to-event mediation analysis via opportunistic infection"],"prefix":"10.1016","volume":"67","author":[{"given":"Nana","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2797-0686","authenticated-orcid":false,"given":"Yongli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107904_bib0001","article-title":"Global, regional, and national burden of HIV\/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021","volume":"11","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0002","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0003","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/QAI.0b013e3182948d82","article-title":"Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003-2009","volume":"63","author":"Zhu","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0004","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(11)70097-4","article-title":"Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study","volume":"11","author":"Zhang","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","article-title":"Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges","volume":"17","author":"Cao","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0006","article-title":"Rapid antiretroviral therapy and treatment outcomes among people living with HIV: exploring the mediating roles of medication adherence","volume":"12","author":"Chen","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-micro-121423-115959","article-title":"Opportunistic fungal infections in Sub-Saharan Africa","volume":"79","author":"Duvenage","year":"2025","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciae051","article-title":"National hospitalization rates and In-hospital mortality rates of HIV-related opportunistic infections in the United States, 2011-2018","volume":"79","author":"Bielick","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068445","article-title":"Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings","volume":"8","author":"Marshall","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0010","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1093\/cid\/ciy013","article-title":"Priorities for decreasing morbidity and mortality in children with advanced HIV disease","volume":"66","author":"Frigati","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0011","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0b013e328333850f","article-title":"Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings","volume":"5","author":"Lawn","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"10.1016\/j.ijantimicag.2026.107904_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/biomtc\/ujae032","article-title":"Direct and indirect treatment effects in the presence of semicompeting risks","volume":"80","author":"Deng","year":"2024","journal-title":"Biometrics"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0013","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S2213-2600(16)30319-8","article-title":"Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial","volume":"4","author":"Kunisaki","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0014","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1097\/CM9.0000000000003383","article-title":"Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection\/acquired immunodeficiency syndrome (2024 edition)","volume":"137","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0015","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1038\/s41467-023-41051-w","article-title":"Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cid\/ciw146","article-title":"Effects of CD4 cell counts and viral load testing on mortality rates in patients with HIV infection receiving antiretroviral treatment: an observational cohort study in rural Southwest China","volume":"63","author":"Shen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/EDE.0000000000001791","article-title":"Multistate approach for stochastic interventions on a time-to-event mediator in the presence of competing risks: a new R command within the CMAverse R package","volume":"36","author":"Wang","year":"2025","journal-title":"Epidemiology"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0018","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1177\/09622802231163331","article-title":"A multistate approach for the study of interventions on an intermediate time-to-event in health disparities research","volume":"32","author":"Valeri","year":"2023","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0019","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jclinepi.2023.09.014","article-title":"The use of the E-value for sensitivity analysis","volume":"163","author":"Chung","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0021","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0022","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0023","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0024","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40121-022-00619-7","article-title":"Late cART initiation consistently driven by Late HIV presentation: a multicenter retrospective cohort study in Taiwan from 2009 to 2019","volume":"11","author":"Lee","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26406","article-title":"The impact of same-day and rapid ART initiation under the Universal Health Coverage programme on HIV outcomes in Thailand: a retrospective real-life cohort study","volume":"28","author":"Teeraananchai","year":"2025","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0026","doi-asserted-by":"crossref","first-page":"1963527","DOI":"10.1080\/16549716.2021.1963527","article-title":"Effect of antiretroviral therapy initiation time and baseline CD4(+) cell counts on AIDS-related mortality among former plasma donors in China: a 21-year retrospective cohort study","volume":"14","author":"Yang","year":"2021","journal-title":"Glob Health Action"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0027","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.10.010408","article-title":"How varying CD4 criteria for treatment initiation was associated with mortality of HIV-patients? A retrospective analysis of electronic health records from Andhra Pradesh, India","volume":"10","author":"Bajpai","year":"2020","journal-title":"J Glob Health"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0028","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jac\/dkac361","article-title":"Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens","volume":"78","author":"Burgos","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijid.2022.06.041","article-title":"Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors","volume":"122","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0030","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/cid\/cix199","article-title":"Incident AIDS or death after initiation of Human Immunodeficiency virus treatment regimens including Raltegravir or Efavirenz among adults in the United States","volume":"64","author":"Cole","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0031","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S2352-3018(22)00046-7","article-title":"Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study","volume":"9","author":"Trickey","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068995","article-title":"Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis","volume":"8","author":"Pillay","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0033","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/S2352-3018(15)00027-2","article-title":"Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study","volume":"2","author":"Molina","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijantimicag.2026.107904_bib0034","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.2024.24543","article-title":"Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel","volume":"333","author":"Gandhi","year":"2025","journal-title":"JAMA"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:49:20Z","timestamp":1788864560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0924857926001913"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107904","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing and regimen of antiretroviral therapy and all-cause mortality in people with HIV: A time-to-event mediation analysis via opportunistic infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107904"}}